Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04933435 · ClinicalTrials.gov registry record · NA

Interventional Radiology Liver Directed Therapies and Hypofractionated Image-Guided Radiation Therapy in Veteran and Non-Veteran, Non-surgical Hepatocellular Carcinoma Patients

A NA study of Liver Cancer, sponsored by Duke University.

Recruiting
Registry status
NA
Development phase
78
Enrollment target
2
Study locations

NCT04933435 is a NA study of Liver Cancer that is actively recruiting participants, run by Duke University. The registered enrollment target is 78 participants, below the 447-participant average among 78 other Liver Cancer trials with a reported enrollment target (83% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04933435, a NA study of Liver Cancer, is actively recruiting participants, sponsored by Duke University.

RECRUITING
Registry status
NA
Development phase
78 participants
Enrollment target
2
Study locations

Study Summary

This is a research study to evaluate change in Quality of Life, as defined by the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core-30 (EORTC C-30), from baseline to 1 month post treatment in two patient cohorts receiving Interventional Radiology Liver Directed Therapies or Hypofractionated Image-Guided Radiation Therapy.

Conditions Studied

Interventions

  • OTHER Quality of life questionnaires

Study Locations (2)

North Carolina

  • Durham Veterans Administration Health Care System (DVAHCS) - Durham
  • Duke Cancer Center - Durham

Trial Details

FieldValue
Enrollment Target 78 participants
Start Date 2020-11-12
Est. Completion 2027-02
Phase NA

Sponsor

Duke University

1,725 total trials

What the Registry Record Tells You About NCT04933435

The ClinicalTrials.gov registry entry for NCT04933435 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 78 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 447-participant average among 78 other Liver Cancer trials with a reported enrollment target (83% lower). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Liver Cancer appearing as the primary indexed condition, and to 1 intervention - of which Quality of life questionnaires is the first listed.

NCT04933435 reports 2 study locations spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT04933435 about?

NCT04933435 is a clinical study titled "Interventional Radiology Liver Directed Therapies and Hypofractionated Image-Guided Radiation Therapy in Veteran and Non-Veteran, Non-surgical Hepatocellular Carcinoma Patients". This is a research study to evaluate change in Quality of Life, as defined by the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core-30 (EORTC C-30), from baseline to 1 month post treatment in two patient cohorts receiving Interventional Radiology Liver Dir...

What is the current status of trial NCT04933435?

This trial is currently recruiting. It is a NA study. The enrollment target is 78 participants. The study started on 2020-11-12. Estimated completion is 2027-02.

What conditions does trial NCT04933435 study?

This clinical trial studies the following conditions: Liver Cancer.

What interventions are being tested in trial NCT04933435?

The interventions under investigation include: Quality of life questionnaires (OTHER).

Who is sponsoring clinical trial NCT04933435?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04933435 being conducted?

This trial has 2 study locations across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Liver Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.